Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015351
Filing Date
2018-11-07
Accepted
2018-11-07 16:29:14
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 540933
2 ex31-1.htm EX-31.1 20862
3 ex31-2.htm EX-31.2 21147
4 ex32.htm EX-32 9720
  Complete submission text file 0001493152-18-015351.txt   4189642

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE hjli-20180930.xml EX-101.INS 753294
6 XBRL SCHEMA FILE hjli-20180930.xsd EX-101.SCH 53030
7 XBRL CALCULATION FILE hjli-20180930_cal.xml EX-101.CAL 53836
8 XBRL DEFINITION FILE hjli-20180930_def.xml EX-101.DEF 240595
9 XBRL LABEL FILE hjli-20180930_lab.xml EX-101.LAB 369695
10 XBRL PRESENTATION FILE hjli-20180930_pre.xml EX-101.PRE 297937
Mailing Address 70 DOPPLER IRVINE CA 92618
Business Address 70 DOPPLER IRVINE CA 92618 949-261-2900
Hancock Jaffe Laboratories, Inc. (Filer) CIK: 0001661053 (see all company filings)

EIN.: 330936180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38325 | Film No.: 181166732
SIC: 3841 Surgical & Medical Instruments & Apparatus